Are Longevity Protocols Designed for Women? The Research Gap No One Talks About

About this video

In this panel excerpt, Yurth argues longevity protocol design still largely ignores women. She says most data come from male subjects because female physiology varies across life stages and across a monthly cycle, making women harder to study, and she warns that some longevity drugs appear to act differently by sex. As an example of a popular generalization, she discusses cold plunging, which she argues may be detrimental for many women, recounting her own years of trying it with misery and no biomarker improvement. Her advice is caution, self-awareness, and checking personal response and markers. She closes with excitement about combining already-approved drugs in new ways rather than waiting for entirely new technologies.

Key takeaways

• Ask whose data a protocol rests on, since Yurth argues female physiology is under-studied in longevity research
• Treat universal wellness advice skeptically, as Yurth’s cold-plunge example shows a celebrated practice may harm some women
• Let your own response and biomarkers arbitrate, Yurth advises, when sex-specific evidence is still weak
• Watch drug combinations of existing approved medicines, which Yurth presents as a faster path to longevity gains than new inventions

Episode details: published September 27, 2026 · 401 views · 3:37 long. Summary written by Self Growth Videos from the episode itself. The longevity and peptide concepts described are Dr. Elizabeth Yurth’s, presented for education — not medical advice. Consult a qualified professional before changing your own health practices. Disclosure: Dr. Yurth is co-founder and Chief Medical Officer of the Boulder Longevity Institute, a clinic, and BLI Academy sells clinician education.

← Previous: The Biggest Longevity Mistake? Why More Isn’t Always Better | Dr. Elizabeth Yurth

All Dr. Elizabeth Yurth videos · Dr. Elizabeth Yurth profile · Boulder Longevity Institute (official site)